MS
KRRO icon

Maven Securities’s Korro Bio KRRO Stock Holding History

Maven Securities’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-70
Closed -$33K – 1194
2021
Q1 		$33K Sell
70
-2,930
-98% -$5.69M ﹤0.01% 1114
2020
Q4 		$5.59M Buy
3,000
+778
+35% +$1.03M 0.55% 45
2020
Q3 		$2.13M Buy
+2,222
New +$2.39M 0.18% 126
2020
Q1 		– Sell
-1,136
Closed -$1.01M – 376
2019
Q4 		$1.01M Buy
+1,136
New +$884K 0.09% 175

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Maven Securities's KRRO Position: Q2 2021 in Review

Maven Securities sold out of Korro Bio (KRRO) in Q2 2021, closing a stake of 70 shares — an estimated $33K sold.

Maven Securities first reported a position in KRRO in Q4 2019 and held it in 4 quarters. The position peaked at $5.59M in Q4 2020. 91 funds tracked by Wall St. Rank hold KRRO as of Q2 2021.

  • Maven Securities reported no remaining Korro Bio position as of Q2 2021 after selling out during the quarter.
  • Maven Securities sold 70 Korro Bio shares in Q2 2021, an estimated $33K.
  • Maven Securities first reported a position in Korro Bio in Q4 2019 and held it in 4 quarters.
  • Maven Securities's Korro Bio position peaked at $5.59M in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Korro Bio as of Q2 2021.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.